首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1461494

全球週邊血管器械市場規模、佔有率、成長分析（按產品類型、應用、最終用戶）- 產業預測，2024-2031 年

Global Peripheral Vascular Devices Market Size, Share, Growth Analysis, By Product Type, By Application(Peripheral artery disease, deep vein thrombosis ), By End user - Industry Forecast 2024-2031

出版日期: 2024年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球週邊血管器械市場規模為108.6億美元，從2023年的114.5億美元成長到2031年的174.3億美元，在預測期內（2024-2031年）預計年複合成長率為5.4。

用於診斷和治療週邊血管疾病的醫療器材的開拓、生產和分銷都是充滿活力且快速擴張的全球週邊血管器材市場的一部分。透過治療靜脈曲張、深層靜脈栓塞症和周邊動脈疾病(PAD) 等多種疾病，該行業正在為改善患者治療效果做出重大貢獻。人口老化和血管疾病盛行率的增加正在增加全世界對尖端、高效的周邊血管設備的需求。週邊血管設備市場的存在是為了向醫療保健專業人員提供用於診斷和治療血管疾病的尖端設備和技術。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

美敦力（美國）
波士頓科學公司（美國）
雅培實驗室（美國）
庫克醫療（美國）
康迪斯公司（美國）
泰爾茂株式會社（日本）
貝克頓迪金森公司（美國）
強生公司（美國）
CR巴德（美國）
康德樂（美國）
血管動力學（美國）
Penumbra, Inc.（美國）
WL Gore & Associates（美國）
Endologix（美國）
微創醫療科技有限公司 (中國)
BTG plc（英國）
Spectranetics 公司（美國）
泰利福公司（美國）
愛德華茲生命科學公司（美國）
倫巴第醫療技術（英國）

簡介目錄

Product Code: SQMIG35A2529

Global Peripheral Vascular Devices Market size was valued at USD 10.86 billion in 2022 and is poised to grow from USD 11.45 billion in 2023 to USD 17.43 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

The development, production, and distribution of medical devices used in the diagnosis and treatment of peripheral vascular illnesses are all included in the dynamic and quickly expanding global market for peripheral vascular devices. By treating a variety of ailments such varicose veins, deep vein thrombosis, and peripheral artery disease (PAD), this industry significantly contributes to better patient outcomes. The need for cutting-edge and efficient peripheral vascular devices is growing globally due to an aging population and an increase in the prevalence of vascular disorders. The peripheral vascular devices market exists to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of vascular diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Vascular Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Vascular Devices Market Segmental Analysis

Global Peripheral Vascular Devices Market is segmented on the basis of product type, application, end user, and region. By product type, the market is segmented into angioplasty balloons, stents, embolic protection devices, peripheral vascular catheters, atherectomy devices, and vascular closure devices. By application, the market is segmented into peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and arteriovenous fistulas. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Peripheral Vascular Devices Market

One major factor propelling the peripheral vascular devices market is the increasing incidence of cardiovascular disorders, including deep vein thrombosis (DVT) and peripheral artery disease (PAD). The World Health Organization (WHO) states that heart disease is the primary cause of death globally. The need for peripheral vascular devices for detection and treatment is rising as a result of the rising prevalence of cardiovascular illnesses.

Restraints in the Global Peripheral Vascular Devices Market

One major barrier to commercial expansion for peripheral vascular devices is their high cost. The cost of research and development, legal regulations, and the use of cutting-edge materials and technologies are just a few of the reasons why these gadgets can be costly. These devices' high price may prevent them from being widely used, especially in poor nations with tight healthcare budgets and difficult reimbursement policies.

Market Trends of the Global Peripheral Vascular Devices Market

Drug-eluting devices are becoming more and more popular in the peripheral vascular devices market. By delivering therapeutic medications straight to the damaged blood arteries, these devices help avoid restenosis (re-narrowing) and lessen the need for repeated procedures. Drug-eluting stents, for instance, improve patients' long-term outcomes by releasing anti-proliferative medications to prevent the formation of scar tissue in the artery.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Peripheral Vascular Devices Market by Product Type

Market Overview
Angioplasty balloons
stents
embolic protection devices
peripheral vascular catheters
atherectomy devices
and vascular closure devices

Global Peripheral Vascular Devices Market by Application

Market Overview
Peripheral artery disease (PAD)
deep vein thrombosis (DVT)
varicose veins
and arteriovenous fistulas.

Global Peripheral Vascular Devices Market by End user

Market Overview
Hospitals
ambulatory surgical centers
and specialty clinics

Global Peripheral Vascular Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C.R. Bard (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTG plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spectranetics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments